Journal of Applied Physiology Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 97: 773-780, 2004. First published April 23, 2004; doi:10.1152/japplphysiol.00107.2004
8750-7587/04 $5.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
97/2/773    most recent
00107.2004v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waters, R. E.
Right arrow Articles by Annex, B. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waters, R. E.
Right arrow Articles by Annex, B. H.

HIGHLIGHTED TOPICS
Skeletal and Cardiac Muscle Blood Flow

Preclinical models of human peripheral arterial occlusive disease: implications for investigation of therapeutic agents

Richard E. Waters,1 Ronald L. Terjung,2 Kevin G. Peters,3 and Brian H. Annex1

1Division of Cardiology, Department of Medicine, Durham Department of Veterans Affairs and Duke University Medical Center, Durham, North Carolina 27705; 2Department of Biomedical Sciences, College of Veterinary Medicine, University of Missouri, Columbia, Missouri 65212; and 3Procter and Gamble Pharmaceuticals, Mason, Ohio 45069

Submitted 2 February 2004 ; accepted in final form 16 April 2004

Peripheral arterial occlusive disease (PAOD) is now recognized as a combination of clinical syndromes that are associated with significant morbidity and mortality. The primary pathophysiology of PAOD is impaired perfusion to the lower extremity. Effective pharmacotherapy designed to increase perfusion in PAOD is lacking, and revascularization options are suboptimal. New and more efficacious therapies that improve blood flow are definitely needed, and thus designing, describing, and validating these new therapies in preclinical PAOD models will be essential. This study describes the various preclinical PAOD models presently in use, correlates the models to human PAOD, and reviews the available end points that can be used to detect a response to therapy.

angiogenesis; endothelial cells; growth factors; perfusion; vascular surgery


Address for reprint requests and other correspondence: B. H. Annex, Durham VA and Duke University Medical Center, 508 Fulton St. (Box 111A), Durham, NC 27705 (E-mail: annex001{at}mc.duke.edu).




This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. Xing, J. Lu, and J. Li
Contribution of nerve growth factor to augmented TRPV1 responses of muscle sensory neurons by femoral artery occlusion
Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1380 - H1387.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
J. C. Taylor, H. T. Yang, M. H. Laughlin, and R. L. Terjung
{alpha}-Adrenergic and neuropeptide Y Y1 receptor control of collateral circuit conductance: influence of exercise training
J. Physiol., December 15, 2008; 586(24): 5983 - 5998.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. M. Krady, J. Zeng, J. Yu, S. MacLauchlan, E. A. Skokos, W. Tian, P. Bornstein, W. C. Sessa, and T. R. Kyriakides
Thrombospondin-2 Modulates Extracellular Matrix Remodeling during Physiological Angiogenesis
Am. J. Pathol., September 1, 2008; 173(3): 879 - 891.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. Xing, Z. Gao, J. Lu, L. I. Sinoway, and J. Li
Femoral artery occlusion augments TRPV1-mediated sympathetic responsiveness
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1262 - H1269.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. W. Ji, F. Mac Gabhann, and A. S. Popel
Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3740 - H3749.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
I. Penuelas, X. L. Aranguren, G. Abizanda, J. M. Marti-Climent, M. Uriz, M. Ecay, M. Collantes, G. Quincoces, J. A. Richter, and F. Prosper
13N-Ammonia PET as a Measurement of Hindlimb Perfusion in a Mouse Model of Peripheral Artery Occlusive Disease
J. Nucl. Med., July 1, 2007; 48(7): 1216 - 1223.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
F. Mac Gabhann, J. W. Ji, and A. S. Popel
VEGF gradients, receptor activation, and sprout guidance in resting and exercising skeletal muscle
J Appl Physiol, February 1, 2007; 102(2): 722 - 734.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.